Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A novel method to measure cardiac index based on ultrasound indicator dilution technology (UIDT) has been developed by Transonic Systems Inc. (Ithaca, NY, USA). The method overcomes many of the limitations that have plagued the existing techniques used to measure cardiac index in critically ill children.

In the proposed investigation, the investigators hope to validate a novel application of an existing technology in critically ill infants and children. The primary aim of this study is to determine the accuracy of cardiac index measured by UIDT when compared to the gold-standard Fick technique. The primary hypothesis is that the average of three consecutive measurements of cardiac index by UIDT will be accurate when compared to the Fick technique. Secondary aims will be to determine the precision of the measurement, the feasibility of the technique with regards to time required and any complications encountered. An exploratory secondary aim of this study is to determine whether central blood volume (CBV) derived from indicator transit time (ITT) correlates with central venous pressure (CVP) and echocardiography derived measures of preload.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Measure Cardiac Output Using Ultrasound Dilution in Mechanically Ventilated Children

NCT01662141

Post Cardiac Surgery

COMPLETED

Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique

NCT00851422

Cardiac Output

COMPLETED

Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Children Using Transthoracic Echocardiography

NCT05054452

Fluid Therapy Hemodynamics Hypovolemia +1 more

UNKNOWN NA

Measurement of Cardiac Output Before and After Cardiopulmonary Bypass.

NCT01103895

Cardiac Output

TERMINATED

Evaluation of Ultrasound of the Heart in Patients With Low Blood Pressure

NCT01723176

Cardiopulmonary Failure

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Output

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: less than 18 years.
* Admission to the CICU (Cardiac Intensive Care Unit) (8S) or MISICU (Medical-Surgical Intensive Care Unit) (7S) of the Children's Hospital Boston.
* Presence of a central venous catheter with its tip in the superior vena cava or a catheter in the pulmonary artery, documented by radiography.
* Requirement for mechanical ventilation via an endotracheal or tracheostomy tube.
* Presence of an arterial catheter.
* Patients must have a two ventricle circulation.

Exclusion Criteria

* Endotracheal tube leak of greater than 10%.
* A significant air leak around the endotracheal tube makes VO2 impossible to measure.
* Presence of relevant intracardiac shunt.
* Intracardiac shunt will decrease the area under the arterial dilution curve unpredictably, making cardiac index calculations unreliable.
* A patent foramen ovale and a single ventricular septal defect less than or equal to 2mm or an atrial septal defect less than or equal to 3mm will be considered irrelevant for the purposes of this study.
* Previous enrollment in an incompatible research study.
* Current or prior diagnosis of heparin induced thrombocytopenia.
* A small amount of heparin is required to flush the extracorporeal AV (Arteriovenous) loop that is required for the measurements.
* Pneumothorax with ongoing air leak.
* An air leak will invalidate the measurement of VO2.

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No